In the last 12 months, insiders at BAXTER INTERNATIONAL INC ($BAX) filed 222 transactions with the SEC: 0 open-market purchases totaling $0 and 4 sales totaling $5,579,360. Net insider sentiment: net selling.
BAXTER INTERNATIONAL INC operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Mason Jeanne K (EVP, Chief HR Officer) — 13 transactions totaling $5,353,586
- Mason Jeanne K (SVP, Human Resources) — 10 transactions totaling $4,969,238
- Toth Christopher A. (EVP,Group Pres, Kidney Care) — 3 transactions totaling $1,468,992
- ALMEIDA JOSE E (Chairman, CEO, President) — 6 transactions totaling $1,219,722
- Rosenbloom David S. (EVP and General Counsel) — 14 transactions totaling $1,050,907
View all SEC Filings for BAXTER INTERNATIONAL INC (BAX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 6620 | $17.69 | 138,216.0000 | 683,000,000 | 4.57% | 0.00% |
| March 6, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 12674 | $17.69 | 125,557.0000 | 683,000,000 | 9.17% | 0.00% |
| March 6, 2026 | Grade Joel T. | EVP and CFO | F | Common Stock, $1 par value | 8153 | $17.69 | 271,674.0000 | 683,000,000 | 2.91% | 0.00% |
| March 6, 2026 | Zielinski Anita A | SVP, CAO and Controller | F | Common Stock, $1 par value | 1932 | $17.69 | 46,281.0000 | 683,000,000 | 4.01% | 0.00% |
| March 6, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | Common Stock, $1 par value | 2848 | $17.69 | 75,045.0000 | 683,000,000 | 3.66% | 0.00% |
| Feb. 27, 2026 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 42735 | $0.00 | 279,828.0000 | 683,000,000 | 18.02% | 0.01% |
| Feb. 27, 2026 | Grade Joel T. | EVP and CFO | A | Stock Option (Right to Buy) | 103448 | $0.00 | 103,448.0000 | 683,000,000 | 9999.99% | 0.02% |
| Feb. 27, 2026 | Zielinski Anita A | SVP, CAO and Controller | A | Common Stock, $1 par value | 30864 | $0.00 | 48,214.0000 | 683,000,000 | 177.89% | 0.00% |
| Feb. 27, 2026 | Hider Andrew P. | President and CEO | A | Stock Option (Right to Buy) | 488506 | $0.00 | 488,506.0000 | 683,000,000 | 9999.99% | 0.07% |
| Feb. 27, 2026 | Hider Andrew P. | President and CEO | A | Common Stock, $1 par value | 201804 | $0.00 | 572,239.0000 | 683,000,000 | 54.48% | 0.03% |
| Feb. 27, 2026 | Rosenbloom David S. | EVP and General Counsel | A | Stock Option (Right to Buy) | 64655 | $0.00 | 64,655.0000 | 683,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | A | Common Stock, $1 par value | 11871 | $0.00 | 29,677.0000 | 683,000,000 | 66.67% | 0.00% |
| Feb. 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | A | Stock Option (Right to Buy) | 43103 | $0.00 | 43,103.0000 | 683,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | A | Common Stock, $1 par value | 17806 | $0.00 | 17,806.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 2, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 1614 | $19.69 | 138,231.0000 | 683,000,000 | 1.15% | 0.00% |
| Feb. 27, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | Common Stock, $1 par value | 23742 | $0.00 | 79,748.0000 | 683,000,000 | 42.39% | 0.00% |
| March 2, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | Common Stock, $1 par value | 1852 | $19.69 | 77,894.0000 | 683,000,000 | 2.32% | 0.00% |
| Feb. 27, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | Stock Option (Right to Buy) | 57471 | $0.00 | 57,471.0000 | 683,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2026 | Rosenbloom David S. | EVP and General Counsel | A | Common Stock, $1 par value | 26709 | $0.00 | 146,173.0000 | 683,000,000 | 22.36% | 0.00% |
| March 2, 2026 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 1336 | $19.69 | 144,837.0000 | 683,000,000 | 0.91% | 0.00% |
| Feb. 13, 2026 | McDonnell Michael R. | Director | A | Common Stock, $1 par value | 1811 | $0.00 | 1,811.0000 | 683,000,000 | 9999.99% | 0.00% |
| Feb. 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | Common Stock, $1 par value | 918 | $21.73 | 56,006.0000 | 683,000,000 | 1.61% | 0.00% |
| Feb. 9, 2026 | Grade Joel T. | EVP and CFO | F | Common Stock, $1 par value | 9144 | $21.73 | 236,904.0000 | 683,000,000 | 3.72% | 0.00% |
| Feb. 9, 2026 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 30504 | $0.00 | 246,048.0000 | 683,000,000 | 14.15% | 0.00% |
| Feb. 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 5770 | $21.73 | 139,846.0000 | 683,000,000 | 3.96% | 0.00% |
| Feb. 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | A | Common Stock, $1 par value | 18951 | $0.00 | 145,616.0000 | 683,000,000 | 14.96% | 0.00% |
| Feb. 9, 2026 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 5225 | $21.73 | 119,464.0000 | 683,000,000 | 4.19% | 0.00% |
| Feb. 9, 2026 | Rosenbloom David S. | EVP and General Counsel | A | Common Stock, $1 par value | 17055 | $0.00 | 124,689.0000 | 683,000,000 | 15.85% | 0.00% |
| Feb. 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | Common Stock, $1 par value | 2273 | $0.00 | 56,924.0000 | 683,000,000 | 4.16% | 0.00% |
| Dec. 12, 2025 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 650 | $19.15 | 199,853.0000 | 683,000,000 | 0.32% | 0.00% |
| Dec. 1, 2025 | Grade Joel T. | EVP and CFO | F | Common Stock, $1 par value | 8288 | $19.08 | 215,151.0000 | 683,000,000 | 3.71% | 0.00% |
| Sept. 2, 2025 | Hider Andrew P. | President and CEO | A | Common Stock, $1 par value | 236237 | $0.00 | 236,237.0000 | 683,000,000 | 9999.99% | 0.03% |
| Sept. 2, 2025 | Hider Andrew P. | President and CEO | A | Common Stock, $1 par value | 131813 | $0.00 | 368,050.0000 | 683,000,000 | 55.80% | 0.02% |
| Sept. 2, 2025 | Hider Andrew P. | President and CEO | A | Stock Option (Right to Buy) | 465651 | $0.00 | 465,651.0000 | 683,000,000 | 9999.99% | 0.07% |
| Sept. 2, 2025 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 102712 | $0.00 | 222,560.0000 | 683,000,000 | 85.70% | 0.02% |
| Sept. 2, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | F | Common Stock, $1 par value | 1848 | $24.17 | 71,948.0000 | 683,000,000 | 2.50% | 0.00% |
| Sept. 2, 2025 | Sonig Alok | EVP,Group President,Pharma | F | Common Stock, $1 par value | 3191 | $24.17 | 128,219.0000 | 683,000,000 | 2.43% | 0.00% |
| Aug. 19, 2025 | Shafer David Brent | Other | F | Common Stock, $1 par value | 31337 | $24.33 | 59,446.0000 | 683,000,000 | 34.52% | 0.00% |
| June 2, 2025 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 16548 | $29.55 | 106,327.0000 | 683,000,000 | 13.47% | 0.00% |
| May 6, 2025 | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 31,222.0000 | 683,000,000 | 29.88% | 0.00% |
| May 6, 2025 | Ampofo William A. II | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 17,299.0000 | 683,000,000 | 71.01% | 0.00% |
| May 6, 2025 | Craig Jeffrey A | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 10,672.0000 | 683,000,000 | 205.88% | 0.00% |
| May 6, 2025 | Oesterle Stephen N. | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 35,847.0000 | 683,000,000 | 25.06% | 0.00% |
| May 6, 2025 | RUSCKOWSKI STEPHEN H | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 16,499.0000 | 683,000,000 | 77.10% | 0.00% |
| May 6, 2025 | SCHLICHTING NANCY M | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 21,850.0000 | 683,000,000 | 48.97% | 0.00% |
| May 6, 2025 | Smith Cathy R | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 30,345.0000 | 683,000,000 | 31.01% | 0.00% |
| May 6, 2025 | MORRISON PATRICIA | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 29,137.0000 | 683,000,000 | 32.72% | 0.00% |
| May 6, 2025 | Wilkes David S. | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 23,906.0000 | 683,000,000 | 42.95% | 0.00% |
| March 6, 2025 | Grade Joel T. | EVP and CFO | F | Common Stock, $1 par value | 4306 | $35.44 | 88,896.0000 | 683,000,000 | 4.62% | 0.00% |
| March 6, 2025 | Zielinski Anita A | SVP, CAO and Controller | A | Common Stock, $1 par value | 17123 | $0.00 | 17,123.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 6, 2025 | Sonig Alok | EVP,Group President,Pharma | F | Common Stock, $1 par value | 10839 | $35.44 | 100,332.0000 | 683,000,000 | 9.75% | 0.00% |
| March 6, 2025 | Sonig Alok | EVP,Group President,Pharma | A | Common Stock, $1 par value | 29966 | $0.00 | 130,298.0000 | 683,000,000 | 29.87% | 0.00% |
| March 6, 2025 | Sonig Alok | EVP,Group President,Pharma | A | Stock Option (Right to Buy) | 99905 | $0.00 | 99,905.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 6, 2025 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 4922 | $35.44 | 104,780.0000 | 683,000,000 | 4.49% | 0.00% |
| March 6, 2025 | Rosenbloom David S. | EVP and General Counsel | A | Common Stock, $1 par value | 17658 | $0.00 | 122,438.0000 | 683,000,000 | 16.85% | 0.00% |
| March 6, 2025 | Rosenbloom David S. | EVP and General Counsel | A | Stock Option (Right to Buy) | 58873 | $0.00 | 58,873.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 9341 | $35.44 | 98,394.0000 | 683,000,000 | 8.67% | 0.00% |
| March 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | A | Common Stock, $1 par value | 26220 | $0.00 | 124,614.0000 | 683,000,000 | 26.65% | 0.00% |
| March 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | A | Stock Option (Right to Buy) | 87417 | $0.00 | 87,417.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 4375 | $35.44 | 183,963.0000 | 683,000,000 | 2.32% | 0.00% |
| March 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | A | Common Stock, $1 par value | 15696 | $0.00 | 199,659.0000 | 683,000,000 | 8.53% | 0.00% |
| March 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | A | Stock Option (Right to Buy) | 52331 | $0.00 | 52,331.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 6, 2025 | Knight Heather | EVP, Chief Operating Officer | F | Common Stock, $1 par value | 13634 | $35.44 | 141,688.0000 | 683,000,000 | 8.78% | 0.00% |
| March 6, 2025 | Knight Heather | EVP, Chief Operating Officer | A | Common Stock, $1 par value | 35674 | $0.00 | 177,362.0000 | 683,000,000 | 25.18% | 0.01% |
| March 6, 2025 | Knight Heather | EVP, Chief Operating Officer | A | Stock Option (Right to Buy) | 118934 | $0.00 | 118,934.0000 | 683,000,000 | 9999.99% | 0.02% |
| March 6, 2025 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 29538 | $0.00 | 118,434.0000 | 683,000,000 | 33.23% | 0.00% |
| March 6, 2025 | Grade Joel T. | EVP and CFO | A | Stock Option (Right to Buy) | 98478 | $0.00 | 98,478.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | F | Common Stock, $1 par value | 3262 | $35.44 | 63,145.0000 | 683,000,000 | 4.91% | 0.00% |
| March 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | A | Common Stock, $1 par value | 9989 | $0.00 | 73,134.0000 | 683,000,000 | 15.82% | 0.00% |
| March 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | A | Stock Option (Right to Buy) | 33302 | $0.00 | 33,302.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 3, 2025 | Sonig Alok | EVP,Group President,Pharma | F | Common Stock, $1 par value | 1936 | $34.86 | 111,171.0000 | 683,000,000 | 1.71% | 0.00% |
| March 3, 2025 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 1479 | $34.86 | 188,339.0000 | 683,000,000 | 0.78% | 0.00% |
| March 3, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 1987 | $34.86 | 107,735.0000 | 683,000,000 | 1.81% | 0.00% |
| March 3, 2025 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 1312 | $34.86 | 109,703.0000 | 683,000,000 | 1.18% | 0.00% |
| March 3, 2025 | Borzi James W | EVP,Chief Suppy Chain Officer | F | Common Stock, $1 par value | 1339 | $34.86 | 66,407.0000 | 683,000,000 | 1.98% | 0.00% |
| March 3, 2025 | Knight Heather | EVP, Chief Operating Officer | F | Common Stock, $1 par value | 3344 | $34.86 | 155,323.0000 | 683,000,000 | 2.11% | 0.00% |
| Feb. 5, 2025 | Shafer David Brent | Interim CEO and Chair | A | Common Stock, $1 par value | 76289 | $0.00 | 89,841.0000 | 683,000,000 | 562.94% | 0.01% |
| Jan. 31, 2025 | Toth Christopher A. | EVP, Group Pres, Kidney Care | F | Common Stock, $1 par value | 25372 | $32.56 | 105,186.0000 | 683,000,000 | 19.43% | 0.00% |
| Dec. 31, 2024 | Toth Christopher A. | EVP,Group Pres, Kidney Care | F | Common Stock, $1 par value | 32610 | $29.16 | 183,876.0000 | 683,000,000 | 15.06% | 0.00% |
| Dec. 13, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | F | Common Stock, $1 par value | 5966 | $30.32 | 568,565.0000 | 683,000,000 | 1.04% | 0.00% |
| Dec. 2, 2024 | Rasul Reazur | EVP,Group Pres,Healthcare | F | Common Stock, $1 par value | 2032 | $33.55 | 109,116.0000 | 683,000,000 | 1.83% | 0.00% |
| Dec. 2, 2024 | Grade Joel T. | EVP and CFO | F | Common Stock, $1 par value | 6612 | $33.55 | 92,457.0000 | 683,000,000 | 6.67% | 0.00% |
| Dec. 2, 2024 | Knight Heather | EVP, Group Pres, Med Products | F | Common Stock, $1 par value | 6041 | $33.55 | 157,674.0000 | 683,000,000 | 3.69% | 0.00% |
| Sept. 9, 2024 | Craig Jeffrey A | Director | A | Common Stock, $1 par value | 3472 | $0.00 | 3,472.0000 | 683,000,000 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Borzi James W | EVP,Chief Supply Chain Officer | F | Common Stock, $1 par value | 1685 | $37.85 | 66,853.0000 | 683,000,000 | 2.46% | 0.00% |
| Sept. 3, 2024 | Sonig Alok | EVP,Group President, Pharma | F | Common Stock, $1 par value | 3054 | $37.85 | 111,603.0000 | 683,000,000 | 2.66% | 0.00% |
| June 3, 2024 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 784 | $34.08 | 108,580.0000 | 683,000,000 | 0.72% | 0.00% |
| June 3, 2024 | Toth Christopher A. | EVP,Group Pres, Kidney Care | F | Common Stock, $1 par value | 15202 | $34.08 | 213,282.0000 | 683,000,000 | 6.65% | 0.00% |
| May 7, 2024 | Wilkes David S. | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 16,274.0000 | 683,000,000 | 57.66% | 0.00% |
| May 7, 2024 | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 23,876.0000 | 683,000,000 | 33.21% | 0.00% |
| May 7, 2024 | Smith Cathy R | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 22,545.0000 | 683,000,000 | 35.87% | 0.00% |
| May 7, 2024 | Shafer David Brent | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 13,257.0000 | 683,000,000 | 81.48% | 0.00% |
| May 7, 2024 | SCHLICHTING NANCY M | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 14,278.0000 | 683,000,000 | 71.49% | 0.00% |
| May 7, 2024 | RUSCKOWSKI STEPHEN H | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 9,068.0000 | 683,000,000 | 191.01% | 0.00% |
| May 7, 2024 | Oesterle Stephen N. | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 27,901.0000 | 683,000,000 | 27.12% | 0.00% |
| May 7, 2024 | MORRISON PATRICIA | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 21,367.0000 | 683,000,000 | 38.61% | 0.00% |
| May 7, 2024 | Ampofo William A. II | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 9,847.0000 | 683,000,000 | 152.81% | 0.00% |
| May 7, 2024 | WILVER PETER M | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 13,267.0000 | 683,000,000 | 81.37% | 0.00% |
| March 6, 2024 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 42867 | $0.00 | 96,623.0000 | 683,000,000 | 79.74% | 0.01% |
| March 6, 2024 | Borzi James W | EVP,Chief Supply Chain Officer | A | Common Stock, $1 par value | 33341 | $0.00 | 67,735.0000 | 683,000,000 | 96.94% | 0.00% |
| March 6, 2024 | Mason Jeanne K | EVP, Chief HR Officer | A | Common Stock, $1 par value | 47630 | $0.00 | 188,481.0000 | 683,000,000 | 33.82% | 0.01% |
| March 6, 2024 | Rasul Reazur | EVP,Group Pres, Healthcare | A | Common Stock, $1 par value | 83353 | $0.00 | 109,187.0000 | 683,000,000 | 322.65% | 0.01% |
| March 6, 2024 | Rosenbloom David S. | EVP and General Counsel | A | Common Stock, $1 par value | 53584 | $0.00 | 108,989.0000 | 683,000,000 | 96.71% | 0.01% |
| March 6, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | A | Common Stock, $1 par value | 142891 | $0.00 | 569,900.0000 | 683,000,000 | 33.46% | 0.02% |
| March 6, 2024 | Knight Heather | EVP,Group Pres,Med Products | A | Common Stock, $1 par value | 107168 | $0.00 | 160,330.0000 | 683,000,000 | 201.59% | 0.02% |
| March 6, 2024 | Sonig Alok | EVP,Group President, Pharma | A | Common Stock, $1 par value | 83353 | $0.00 | 113,454.0000 | 683,000,000 | 276.91% | 0.01% |
| March 6, 2024 | Stevens Brian | SVP, CAO & Controller | A | Common Stock, $1 par value | 14289 | $0.00 | 67,538.0000 | 683,000,000 | 26.83% | 0.00% |
| March 6, 2024 | Toth Christopher A. | EVP,Group Pres, Kidney Care | A | Common Stock, $1 par value | 119076 | $0.00 | 227,761.0000 | 683,000,000 | 109.56% | 0.02% |
| March 4, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | F | Common Stock, $1 par value | 4779 | $42.50 | 427,009.0000 | 683,000,000 | 1.11% | 0.00% |
| March 4, 2024 | Borzi James W | EVP,Chief Supply Chain Officer | F | Common Stock, $1 par value | 420 | $42.50 | 34,394.0000 | 683,000,000 | 1.21% | 0.00% |
| March 4, 2024 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 475 | $42.50 | 140,851.0000 | 683,000,000 | 0.34% | 0.00% |
| March 4, 2024 | Knight Heather | EVP,Group Pres, Med Products | F | Common Stock, $1 par value | 1320 | $42.50 | 53,162.0000 | 683,000,000 | 2.42% | 0.00% |
| March 4, 2024 | Rasul Reazur | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 522 | $42.50 | 25,834.0000 | 683,000,000 | 1.98% | 0.00% |
| March 4, 2024 | Stevens Brian | SVP, CAO & Controller | F | Common Stock, $1 par value | 545 | $42.50 | 53,249.0000 | 683,000,000 | 1.01% | 0.00% |
| March 1, 2024 | Rosenbloom David S. | EVP and General Counsel | F | Common Stock, $1 par value | 1416 | $41.01 | 55,405.0000 | 683,000,000 | 2.49% | 0.00% |
| March 1, 2024 | Mason Jeanne K | EVP, Chief HR Officer | M | Common Stock, $1 par value | 64488 | $37.17 | 206,778.0000 | 683,000,000 | 45.32% | 0.01% |
| March 1, 2024 | Sonig Alok | EVP, Group President, Pharma | F | Common Stock, $1 par value | 1832 | $41.01 | 30,101.0000 | 683,000,000 | 5.74% | 0.00% |
| March 1, 2024 | Stevens Brian | SVP, CAO & Controller | F | Common Stock, $1 par value | 673 | $41.01 | 53,795.0000 | 683,000,000 | 1.24% | 0.00% |
| March 1, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | F | Common Stock, $1 par value | 9701 | $41.01 | 431,788.0000 | 683,000,000 | 2.20% | 0.00% |
| March 1, 2024 | Borzi James W | EVP, Chief Supply Chain Offcr | F | Common Stock, $1 par value | 852 | $41.01 | 34,814.0000 | 683,000,000 | 2.39% | 0.00% |
| March 1, 2024 | Knight Heather | EVP, Group Pres, Med Products | F | Common Stock, $1 par value | 2154 | $41.01 | 54,483.0000 | 683,000,000 | 3.80% | 0.00% |
| March 1, 2024 | Mason Jeanne K | EVP, Chief HR Officer | M | Stock Option (Right to Buy) | 64488 | $0.00 | 0.0000 | 683,000,000 | 100.00% | 0.01% |
| March 1, 2024 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 963 | $41.01 | 141,326.0000 | 683,000,000 | 0.68% | 0.00% |
| March 1, 2024 | Mason Jeanne K | EVP, Chief HR Officer | S | Common Stock, $1 par value | 64488 | $40.61 | 142,290.0000 | 683,000,000 | 31.19% | 0.01% |
| March 1, 2024 | Rasul Reazur | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 1538 | $41.01 | 26,357.0000 | 683,000,000 | 5.51% | 0.00% |
| Feb. 12, 2024 | Knight Heather | EVP, Group Pres, Med Products | F | Common Stock, $1 par value | 356 | $40.31 | 56,602.0000 | 683,000,000 | 0.63% | 0.00% |
| Feb. 12, 2024 | Knight Heather | EVP, Group Pres, Med Products | A | Common Stock, $1 par value | 1027 | $0.00 | 56,958.0000 | 683,000,000 | 1.84% | 0.00% |
| Feb. 12, 2024 | Rasul Reaz | EVP, Group Pres, Healthcare | A | Common Stock, $1 par value | 716 | $0.00 | 28,143.0000 | 683,000,000 | 2.61% | 0.00% |
| Feb. 12, 2024 | Rasul Reaz | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 248 | $40.31 | 27,895.0000 | 683,000,000 | 0.88% | 0.00% |
| Feb. 12, 2024 | Stevens Brian | SVP, CAO & Controller | A | Common Stock, $1 par value | 821 | $0.00 | 54,753.0000 | 683,000,000 | 1.52% | 0.00% |
| Feb. 12, 2024 | Stevens Brian | SVP, CAO & Controller | F | Common Stock, $1 par value | 284 | $40.31 | 54,469.0000 | 683,000,000 | 0.52% | 0.00% |
| Feb. 12, 2024 | Mason Jeanne K | EVP, Chief HR Officer | A | Common Stock, $1 par value | 4602 | $0.00 | 143,753.0000 | 683,000,000 | 3.31% | 0.00% |
| Feb. 12, 2024 | Mason Jeanne K | EVP, Chief HR Officer | F | Common Stock, $1 par value | 1463 | $40.31 | 142,290.0000 | 683,000,000 | 1.02% | 0.00% |
| Feb. 12, 2024 | Borzi James W | EVP, Chief Supply Chain Office | A | Common Stock, $1 par value | 4184 | $0.00 | 36,977.0000 | 683,000,000 | 12.76% | 0.00% |
| Feb. 12, 2024 | Borzi James W | EVP, Chief Supply Chain Office | F | Common Stock, $1 par value | 1311 | $40.31 | 35,666.0000 | 683,000,000 | 3.55% | 0.00% |
| Feb. 12, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | A | Common Stock, $1 par value | 32884 | $0.00 | 452,352.0000 | 683,000,000 | 7.84% | 0.00% |
| Feb. 12, 2024 | ALMEIDA JOSE E | Chairman, CEO, President | F | Common Stock, $1 par value | 10863 | $40.31 | 441,489.0000 | 683,000,000 | 2.40% | 0.00% |
| Dec. 1, 2023 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 27988 | $0.00 | 27,988.0000 | 683,000,000 | 9999.99% | 0.00% |
| Dec. 1, 2023 | Stevens Brian | SVP, CAO & Controller | A | Common Stock, $1 par value | 13994 | $0.00 | 53,532.0000 | 683,000,000 | 35.39% | 0.00% |
| Dec. 1, 2023 | Grade Joel T. | EVP and CFO | A | Stock Option (Right to Buy) | 102273 | $0.00 | 102,273.0000 | 683,000,000 | 9999.99% | 0.01% |
| Dec. 1, 2023 | Grade Joel T. | EVP and CFO | A | Common Stock, $1 par value | 25189 | $0.00 | 53,177.0000 | 683,000,000 | 90.00% | 0.00% |
| Sept. 1, 2023 | Borzi James W | EVP, Chief Supply Chain Office | A | Common Stock, $1 par value | 12016 | $0.00 | 32,300.0000 | 683,000,000 | 59.24% | 0.00% |
| Sept. 1, 2023 | Sonig Alok | EVP, Group President, Pharm | F | Common Stock, $1 par value | 2059 | $40.60 | 31,512.0000 | 683,000,000 | 6.13% | 0.00% |
| Aug. 21, 2023 | RUSCKOWSKI STEPHEN H | Director | A | Common Stock, $1 par value | 3049 | $0.00 | 3,049.0000 | 683,000,000 | 9999.99% | 0.00% |
| June 29, 2023 | Ampofo William A. II | Director | A | Common Stock, $ par value | 3811 | $0.00 | 3,811.0000 | 683,000,000 | 9999.99% | 0.00% |
| June 1, 2023 | Toth Christopher A. | EVP, Group Pres, Kidney Care | A | Common Stock, $1 par value | 106358 | $0.00 | 106,358.0000 | 683,000,000 | 9999.99% | 0.02% |
| June 1, 2023 | Stevens Brian | SVP,Interim CFO,CAO&Cntrl | A | Common Stock, $1 par value | 5909 | $0.00 | 38,982.0000 | 683,000,000 | 17.87% | 0.00% |
| June 1, 2023 | Rosenbloom David S. | SVP and General Counsel | F | Common Stock, $1 par value | 762 | $41.23 | 55,645.0000 | 683,000,000 | 1.35% | 0.00% |
| May 2, 2023 | SCHLICHTING NANCY M | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 8,099.0000 | 683,000,000 | 129.69% | 0.00% |
| May 2, 2023 | Oesterle Stephen N. | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 21,336.0000 | 683,000,000 | 27.28% | 0.00% |
| May 2, 2023 | MORRISON PATRICIA | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 14,984.0000 | 683,000,000 | 43.92% | 0.00% |
| May 2, 2023 | Mahoney Michael F | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 30,089.0000 | 683,000,000 | 17.92% | 0.00% |
| May 2, 2023 | WILVER PETER M | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 7,111.0000 | 683,000,000 | 180.18% | 0.00% |
| May 2, 2023 | Wilkes David S. | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 10,034.0000 | 683,000,000 | 83.74% | 0.00% |
| May 2, 2023 | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 17,894.0000 | 683,000,000 | 34.33% | 0.00% |
| May 2, 2023 | Smith Cathy R | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 16,130.0000 | 683,000,000 | 39.57% | 0.00% |
| May 2, 2023 | Shafer David Brent | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 7,101.0000 | 683,000,000 | 180.89% | 0.00% |
| March 20, 2023 | STROUCKEN ALBERT P L | Director | M | Common Stock, $1 par value | 3930 | $36.93 | 41,461.0000 | 683,000,000 | 10.47% | 0.00% |
| March 20, 2023 | Knight Heather | EVP, Group Pres, Medical | F | Common Stock, $1 par value | 212 | $38.19 | 53,110.0000 | 683,000,000 | 0.40% | 0.00% |
| March 20, 2023 | Rasul Reaz | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 151 | $38.19 | 26,765.0000 | 683,000,000 | 0.56% | 0.00% |
| March 20, 2023 | Stevens Brian | SVP. CAO and Controller | F | Common Stock, $1 par value | 161 | $38.19 | 32,896.0000 | 683,000,000 | 0.49% | 0.00% |
| March 20, 2023 | STROUCKEN ALBERT P L | Director | M | Stock Option (Right to Buy) | 3930 | $0.00 | 0.0000 | 683,000,000 | 100.00% | 0.00% |
| March 20, 2023 | STROUCKEN ALBERT P L | Director | S | Common Stock, $1 par value | 3930 | $37.52 | 37,531.0000 | 683,000,000 | 9.48% | 0.00% |
| March 3, 2023 | Stevens Brian | SVP, CAO and Controller | F | Common Stock, $1 par value | 184 | $39.94 | 33,058.0000 | 683,000,000 | 0.55% | 0.00% |
| March 3, 2023 | Rasul Reaz | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 148 | $39.94 | 26,917.0000 | 683,000,000 | 0.55% | 0.00% |
| March 3, 2023 | Knight Heather | EVP, Group Pres, Medical | F | Common Stock, $1 par value | 220 | $39.94 | 53,322.0000 | 683,000,000 | 0.41% | 0.00% |
| March 2, 2023 | Knight Heather | EVP, Group Pres, Medical | F | Common Stock, $1 par value | 1067 | $39.62 | 53,543.0000 | 683,000,000 | 1.95% | 0.00% |
| March 2, 2023 | Franzi Cristiano | SVP, President, EMEA | F | Common Stock, $1 par value | 146 | $39.62 | 102,145.0000 | 683,000,000 | 0.14% | 0.00% |
| March 2, 2023 | Borzi James W | SVP, Global Supply Chain | F | Common Stock, $1 par value | 474 | $39.62 | 20,078.0000 | 683,000,000 | 2.31% | 0.00% |
| March 2, 2023 | ALMEIDA JOSE E | Chairman, CEO and President | F | Common Stock, $1 par value | 4642 | $39.62 | 408,453.0000 | 683,000,000 | 1.12% | 0.00% |
| March 2, 2023 | SACCARO JAMES | EVP, Chief Financial Officer | F | Common Stock, $1 par value | 1061 | $39.62 | 177,899.0000 | 683,000,000 | 0.59% | 0.00% |
| March 2, 2023 | Mason Jeanne K | SVP, Human Resources | F | Common Stock, $1 par value | 460 | $39.62 | 138,821.0000 | 683,000,000 | 0.33% | 0.00% |
| March 2, 2023 | Stevens Brian | SVP, CAO and Controller | F | Common Stock, $1 par value | 418 | $39.62 | 33,242.0000 | 683,000,000 | 1.24% | 0.00% |
| March 2, 2023 | Rasul Reaz | EVP, Group Pres, Healthcare | F | Common Stock, $1 par value | 416 | $39.62 | 27,066.0000 | 683,000,000 | 1.51% | 0.00% |
| March 2, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | F | Common Stock, $1 par value | 271 | $39.62 | 22,625.0000 | 683,000,000 | 1.18% | 0.00% |
| March 1, 2023 | Mason Jeanne K | SVP, Human Resources | A | Stock Option (Right to Buy) | 43496 | $0.00 | 43,496.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Sonig Alok | EVP, Group President, Pharm | A | Common Stock, $1 par value | 15428 | $0.00 | 33,226.0000 | 683,000,000 | 86.68% | 0.00% |
| March 1, 2023 | Sonig Alok | EVP, Group President, Pharm | A | Stock Option (Right to Buy) | 63965 | $0.00 | 63,965.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Rasul Reaz | EVP, Group Pres, Healthcare | A | Common Stock, $1 par value | 15428 | $0.00 | 27,482.0000 | 683,000,000 | 127.99% | 0.00% |
| March 1, 2023 | Rasul Reaz | EVP, Group Pres, Healthcare | A | Stock Option (Right to Buy) | 63965 | $0.00 | 63,965.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Knight Heather | EVP, Group Pres, Medical | A | Common Stock, $1 par value | 21600 | $0.00 | 54,611.0000 | 683,000,000 | 65.43% | 0.00% |
| March 1, 2023 | Knight Heather | EVP, Group Pres, Medical | A | Stock Option (Right to Buy) | 89551 | $0.00 | 89,551.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Stevens Brian | SVP, CAO and Controller | A | Common Stock, $1 par value | 6788 | $0.00 | 33,660.0000 | 683,000,000 | 25.26% | 0.00% |
| March 1, 2023 | Stevens Brian | SVP, CAO and Controller | A | Stock Option (Right to Buy) | 14072 | $0.00 | 14,072.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | SACCARO JAMES | EVP, Chief Financial Officer | A | Common Stock, $1 par value | 22217 | $0.00 | 178,961.0000 | 683,000,000 | 14.17% | 0.00% |
| March 1, 2023 | SACCARO JAMES | EVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 92109 | $0.00 | 92,109.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Rosenbloom David S. | SVP and General Counsel | A | Common Stock, $1 par value | 13885 | $0.00 | 56,101.0000 | 683,000,000 | 32.89% | 0.00% |
| March 1, 2023 | Rosenbloom David S. | SVP and General Counsel | A | Stock Option (Right to Buy) | 57568 | $0.00 | 57,568.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Mason Jeanne K | SVP, Human Resources | A | Common Stock, $1 par value | 10491 | $0.00 | 139,282.0000 | 683,000,000 | 8.15% | 0.00% |
| March 1, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | A | Common Stock, $1 par value | 6171 | $0.00 | 22,896.0000 | 683,000,000 | 36.90% | 0.00% |
| March 1, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | A | Stock Option (Right to Buy) | 25586 | $0.00 | 25,586.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Franzi Cristiano | SVP, President, EMEA | A | Common Stock, $1 par value | 15428 | $0.00 | 77,607.0000 | 683,000,000 | 24.81% | 0.00% |
| March 1, 2023 | Franzi Cristiano | SVP, President, EMEA | A | Common Stock, $1 par value | 24685 | $0.00 | 102,292.0000 | 683,000,000 | 31.81% | 0.00% |
| March 1, 2023 | Franzi Cristiano | SVP, President, EMEA | A | Stock Option (Right to Buy) | 63965 | $0.00 | 63,965.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | Flynn Steven | SVP, President, APAC | A | Common Stock, $1 par value | 6171 | $0.00 | 18,737.0000 | 683,000,000 | 49.11% | 0.00% |
| March 1, 2023 | Flynn Steven | SVP, President, APAC | A | Common Stock, $1 par value | 12343 | $0.00 | 31,080.0000 | 683,000,000 | 65.88% | 0.00% |
| March 1, 2023 | Flynn Steven | SVP, President, APAC | A | Stock Option (Right to Buy) | 25586 | $0.00 | 25,586.0000 | 683,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Borzi James W | SVP, Global Supply Chain | A | Common Stock, $1 par value | 8640 | $0.00 | 20,552.0000 | 683,000,000 | 72.53% | 0.00% |
| March 1, 2023 | Borzi James W | SVP, Global Supply Chain | A | Stock Option (Right to Buy) | 35820 | $0.00 | 35,820.0000 | 683,000,000 | 9999.99% | 0.01% |
| March 1, 2023 | ALMEIDA JOSE E | Chairman, CEO and President | A | Common Stock, $1 par value | 67884 | $0.00 | 413,096.0000 | 683,000,000 | 19.66% | 0.01% |
| March 1, 2023 | ALMEIDA JOSE E | Chairman, CEO and President | A | Stock Option (Right to Buy) | 281445 | $0.00 | 281,445.0000 | 683,000,000 | 9999.99% | 0.04% |
| Feb. 21, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | M | Stock Option (Right to Buy) | 4163 | $0.00 | 0.0000 | 683,000,000 | 100.00% | 0.00% |
| Feb. 21, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | M | Common Stock, $1 par value | 4163 | $37.82 | 20,538.0000 | 683,000,000 | 25.42% | 0.00% |
| Feb. 21, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | S | Common Stock, $1 par value | 3813 | $40.50 | 16,725.0000 | 683,000,000 | 18.57% | 0.00% |
| Feb. 13, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | F | Common Stock, $1 par value | 715 | $40.50 | 16,375.0000 | 683,000,000 | 4.18% | 0.00% |
| Feb. 13, 2023 | Mason Jeanne K | SVP, Human Resources | A | Common Stock, $1 par value | 3621 | $0.00 | 129,852.0000 | 683,000,000 | 2.87% | 0.00% |
| Feb. 13, 2023 | SACCARO JAMES | EVP, Chief Financial Officer | F | Common Stock, $1 par value | 1059 | $40.50 | 156,744.0000 | 683,000,000 | 0.67% | 0.00% |
| Feb. 13, 2023 | SACCARO JAMES | EVP, Chief Financial Officer | A | Common Stock, $1 par value | 3362 | $0.00 | 157,803.0000 | 683,000,000 | 2.18% | 0.00% |
| Feb. 13, 2023 | Stevens Brian | SVP, CAO and Controller | F | Common Stock, $1 par value | 224 | $40.50 | 26,872.0000 | 683,000,000 | 0.83% | 0.00% |
| Feb. 13, 2023 | Stevens Brian | SVP, CAO and Controller | A | Common Stock, $1 par value | 646 | $0.00 | 27,096.0000 | 683,000,000 | 2.44% | 0.00% |
| Feb. 13, 2023 | ALMEIDA JOSE E | Chairman, CEO and President | F | Common Stock, $1 par value | 10053 | $40.50 | 345,212.0000 | 683,000,000 | 2.83% | 0.00% |
| Feb. 13, 2023 | ALMEIDA JOSE E | Chairman, CEO and President | A | Common Stock, $1 par value | 31044 | $0.00 | 355,265.0000 | 683,000,000 | 9.57% | 0.00% |
| Feb. 13, 2023 | Flynn Steven | SVP, President, APAC | A | Common Stock, $1 par value | 516 | $0.00 | 12,502.0000 | 683,000,000 | 4.31% | 0.00% |
| Feb. 13, 2023 | Franzi Cristiano | SVP, President, EMEA | F | Common Stock, $1 par value | 275 | $40.50 | 62,179.0000 | 683,000,000 | 0.44% | 0.00% |
| Feb. 13, 2023 | Franzi Cristiano | SVP, President, EMEA | A | Common Stock, $1 par value | 5174 | $0.00 | 62,454.0000 | 683,000,000 | 9.03% | 0.00% |
| Feb. 13, 2023 | Kunzler Jacqueline | SVP, Chief Quality Officer | A | Common Stock, $1 par value | 2068 | $0.00 | 17,090.0000 | 683,000,000 | 13.77% | 0.00% |
| Feb. 13, 2023 | Mason Jeanne K | SVP, Human Resources | F | Common Stock, $1 par value | 1061 | $40.50 | 128,791.0000 | 683,000,000 | 0.82% | 0.00% |
| Jan. 17, 2023 | Mason Jeanne K | SVP, Human Resources | M | Common Stock, $1 par value | 59477 | $37.82 | 185,708.0000 | 683,000,000 | 47.12% | 0.01% |
| Jan. 17, 2023 | Mason Jeanne K | SVP, Human Resources | M | Stock Option (Right to Buy) | 19825 | $0.00 | 39,652.0000 | 683,000,000 | 33.33% | 0.00% |
| Jan. 17, 2023 | Mason Jeanne K | SVP, Human Resources | M | Stock Option (Right to Buy) | 19826 | $0.00 | 0.0000 | 683,000,000 | 100.00% | 0.00% |
| Jan. 17, 2023 | Mason Jeanne K | SVP, Human Resources | M | Stock Option (Right to Buy) | 19826 | $0.00 | 19,826.0000 | 683,000,000 | 50.00% | 0.00% |
| Jan. 17, 2023 | Mason Jeanne K | SVP, Human Resources | S | Common Stock, $1 par value | 59477 | $44.70 | 126,231.0000 | 683,000,000 | 32.03% | 0.01% |